HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schectman, J. M. Articles by Voss, J. D. Search for Related Content PubMed PubMed Citation Articles by Schectman, J. M. Articles by Voss, J. D. Social Bookmarking                What's this?

The Association Between Diabetes Metabolic Control and Drug Adherence in an Indigent Population

Department of Medicine, University of Virginia, Charlottesville, Virginia

OBJECTIVE—Studies of the association between diabetes metabolic control and adherence to drug therapy have yielded conflicting results. Because low socioeconomic and minority populations have poorer diabetes outcomes and greater barriers to adherence, we examined the relationship between adherence and diabetes metabolic control in a large indigent population.

RESEARCH DESIGN AND METHODS—The study population consisted of patients receiving medical care from a university-based internal medicine clinic serving a low-income population in rural central Virginia. The sample comprised 810 patients with type 2 diabetes who received oral diabetes medications from the clinic pharmacy and had at least one HbA_1c determination during the study period. Multiple linear regression was used to examine the association of HbA_1c level as well as change in HbA_1c level with medication adherence, demographic, and clinical characteristics.

RESULTS—Better metabolic control was independently associated with greater medication adherence, increasing age, white (versus African-American) race, and lower intensity of drug therapy. For each 10% increment in drug adherence, HbA_1c decreased by 0.16% (P < 0.0001). Controlling for other demographic and clinical variables, the mean HbA_1c of African-Americans was 0.29% higher than that of whites (P = 0.04). Additionally, the intensity of diabetes drug therapy for African-Americans was lower, as was their measured adherence to it. There was no association between metabolic control and gender, income, encounter frequency, frequency of HbA_1c testing, or continuity of care.

CONCLUSIONS—Adherence to medication regimens for type 2 diabetes is strongly associated with metabolic control in an indigent population; African-Americans have lower adherence and worse metabolic control. Greater efforts are clearly needed to facilitate diabetes self-management behaviors of low-income populations and foster culturally sensitive and appropriate care for minority groups.

Abbreviations: UVA, University of Virginia

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. S. Adams, C. M. Trinacty, F. Zhang, K. Kleinman, R. W. Grant, J. B. Meigs, S. B. Soumerai, and D. Ross-Degnan Medication Adherence and Racial Differences in A1C Control Diabetes Care, May 1, 2008; 31(5): 916 - 921. [Abstract] [Full Text] [PDF]

				P. S. Odegard and K. Capoccia Medication Taking and Diabetes: A Systematic Review of the Literature The Diabetes Educator, November 1, 2007; 33(6): 1014 - 1029. [Abstract] [Full Text] [PDF]

				R. O. Pierce Jr Ethnic and Racial Disparities in Diagnosis, Treatment, and Follow-up Care J. Am. Acad. Ortho. Surg., September 1, 2007; 15(suppl_1): S8 - S12. [Abstract] [Full Text] [PDF]

				T. N. Erickson, E. B. Devine, T. S. O'Young, L. J. Hanson, B. French, and C. Brennan Effect of switching medically vulnerable patients with uncontrolled diabetes from isophane insulin human to insulin glargine. Am. J. Health Syst. Pharm., October 1, 2006; 63(19): 1862 - 1871. [Abstract] [Full Text] [PDF]

				I. D Kalsekar, S. S Madhavan, M. M Amonkar, E. H Makela, V. G Scott, S. M Douglas, and B. L M. Elswick Depression in Patients with Type 2 Diabetes: Impact on Adherence to Oral Hypoglycemic Agents Ann. Pharmacother., April 1, 2006; 40(4): 605 - 611. [Abstract] [Full Text] [PDF]

				G. Woodward, C. van Walraven, and J. E. Hux Utilization and outcomes of HbA1c testing: a population-based study Can. Med. Assoc. J., January 31, 2006; 174(3): 327 - 329. [Full Text] [PDF]

				J. J. Lefante Jr, G. N. Harmon, W. Roy, S. Fontenot, K. Brown, and L. Webber The Effect of Medication Reviews in a Rural Community Pharmacy Assistance Program: The Cenla Medication Access Program Journal of Pharmacy Practice, December 1, 2005; 18(6): 486 - 492. [Abstract] [PDF]

				M C Marshall Jr Diabetes in African Americans Postgrad. Med. J., December 1, 2005; 81(962): 734 - 740. [Abstract] [Full Text] [PDF]

				M. K. Rhee, W. Slocum, D. C. Ziemer, S. D. Culler, C. B. Cook, I. M. El-Kebbi, D. L. Gallina, C. Barnes, and L. S. Phillips Patient Adherence Improves Glycemic Control The Diabetes Educator, March 1, 2005; 31(2): 240 - 250. [Abstract] [Full Text] [PDF]

				J. A. Cramer and M. J. Pugh The Influence of Insulin Use on Glycemic Control: How well do adults follow prescriptions for insulin? Diabetes Care, January 1, 2005; 28(1): 78 - 83. [Abstract] [Full Text] [PDF]

				M. Pladevall, L. K. Williams, L. A. Potts, G. Divine, H. Xi, and J. Elston Lafata Clinical Outcomes and Adherence to Medications Measured by Claims Data in Patients With Diabetes Diabetes Care, December 1, 2004; 27(12): 2800 - 2805. [Abstract] [Full Text] [PDF]

				E. J. Mayer-Davis, A. M. D'Antonio, S. M. Smith, G. Kirkner, S. Levin Martin, D. Parra-Medina, and R. Schultz Pounds Off With Empowerment (POWER): A Clinical Trial of Weight Management Strategies for Black and White Adults With Diabetes Who Live in Medically Underserved Rural Communities Am J Public Health, October 1, 2004; 94(10): 1736 - 1742. [Abstract] [Full Text] [PDF]

				D. T. Lau and D. P. Nau Oral Antihyperglycemic Medication Nonadherence and Subsequent Hospitalization Among Individuals With Type 2 Diabetes Diabetes Care, September 1, 2004; 27(9): 2149 - 2153. [Abstract] [Full Text] [PDF]

				K. Krapek, K. King, S. S Warren, K. G George, D. A Caputo, K. Mihelich, E. M Holst, M. B Nichol, S. G Shi, K. B Livengood, et al. Medication Adherence and Associated Hemoglobin A1c in Type 2 Diabetes Ann. Pharmacother., September 1, 2004; 38(9): 1357 - 1362. [Abstract] [Full Text] [PDF]

				J. A. Cramer A Systematic Review of Adherence With Medications for Diabetes Diabetes Care, May 1, 2004; 27(5): 1218 - 1224. [Abstract] [Full Text] [PDF]

				J. D. Piette, M. Heisler, and T. H. Wagner Problems Paying Out-of-Pocket Medication Costs Among Older Adults With Diabetes Diabetes Care, February 1, 2004; 27(2): 384 - 391. [Abstract] [Full Text] [PDF]

				Y.-F. Kuo, M. A. Raji, K. S. Markides, L. A. Ray, D. V. Espino, and J. S. Goodwin Inconsistent Use of Diabetes Medications, Diabetes Complications, and Mortality in Older Mexican Americans Over a 7-Year Period: Data from the Hispanic Established Population for the Epidemiologic Study of the Elderly Diabetes Care, November 1, 2003; 26(11): 3054 - 3060. [Abstract] [Full Text] [PDF]

				N. de Rekeneire, R. N. Rooks, E. M. Simonsick, R. I. Shorr, L. H. Kuller, A. V. Schwartz, and T. B. Harris Racial Differences in Glycemic Control in a Well-Functioning Older Diabetic Population: Findings from the Health, Aging and Body Composition study Diabetes Care, July 1, 2003; 26(7): 1986 - 1992. [Abstract] [Full Text] [PDF]

				M. B. Davidson The Case for "Outsourcing" Diabetes Care Diabetes Care, May 1, 2003; 26(5): 1608 - 1612. [Full Text] [PDF]